je.st
news
Tag: findings
New Findings Show Durable Anti-Tumor Activity with KEYTRUDA (pembrolizumab), Mercks Anti-PD-1 Therapy, in Patients with Advanced Head and Neck Cancer, Regardless of PD-L1 Expression Status
2015-05-29 20:06:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Results from KEYNOTE-012, the First and Largest Study to Date of an Anti-PD-1 Therapy in Head and Neck Cancer, to be Presented at 2015 ASCO Annual Meeting KEYTRUDA Monotherapy Achieved Overall Response Rate of 25 Percent in Heavily Pre-treated Patients Merck is Advancing a Broad Head and Neck Clinical Program for KEYTRUDA with Five Clinical Trials, Across Multiple Lines of Therapy and in Combination with Other Agents KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced new investigational data evaluating KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, as a monotherapy from the KEYNOTE-012 Phase 1b study in 132 pre-treated patients with recurrent or metastatic head and neck cancer, regardless of PD-L1 expression status. Language: English Contact: MerckMedia:Pamela Eisele, 267-664-0282Claire Mulhearn, 908-200-1889orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: show
advanced
status
head
Item 547 2 Final Findings & Decision
2015-05-23 02:01:47| PortlandOnline
PDF Document, 1,180kbCategory: Current Agenda Items
Tags: item
final
decision
findings
RCT findings back probiotic strain to shorten duration of cold and flu: Chr Hansen study
2015-05-22 06:22:57| Food - Topix.net
The world's biggest clinical study on the immune effects of probiotics has found that the L. casei 431 strain could reduce the duration of symptoms from the common cold and flu - though no differences were found in the incidence or severity of illness. Writing in The American Journal of Clinical Nutrition , researchers investigated the effect of the probiotic strain Lactobacillus paracasei subsp.
Tags: back
study
cold
duration
RCT findings back probiotic strain to shorten duration of cold and flu: Chr Hansen study
2015-05-22 04:00:00| Chemicals - Topix.net
The world's biggest clinical study on the immune effects of probiotics has found that the L. casei 431 strain could reduce the duration of symptoms from the common cold and flu - though no differences were found in the incidence or severity of illness. Writing in The American Journal of Clinical Nutrition , researchers investigated the effect of the probiotic strain Lactobacillus paracasei subsp.
Tags: back
study
cold
duration
Decade-long study wins Heinz Award after findings include link between air pollution, obesity
2015-05-18 09:48:03| Food - Topix.net
That was just one of the more surprising findings of a decade-long public health study by Frederica Perera, an environmental health researcher at Columbia University and one of five winners of this year's Heinz Awards. Dr. Perera's research tracked the pre- and post-natal health of 720 mother-child pairs in New York City.
Sites : [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] next »